LATEST NEWS

Promising antibody may prove useful against deadly outbreaks
Scientists capture first look at key viral structure within infected host cells
Prebys Foundation celebrates ground-breaking female researchers
LJI President and CEO celebrated among California’s leading life sciences innovators
LJI researchers reveal a hidden side of how Ebola virus replicates inside host cells
New findings emphasize the benefits of antibody cocktails over monotherapy approaches
Jingru Fang shares how her Ph.D. research inspired a vivid painting
To treat Ebola virus infections, researchers are taking a close look at a key piece of the virus: polymerase.
LJI team uncovers how one odd antibody does some heavy lifting
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
New study highlights VP40 as a promising therapeutic target
The Beacon optofluidic technology will be used to speed the identification of lifesaving treatments for deadly viruses including Ebola, Lassa and others.